References
- Berdy J. 2012. Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot. 65(8):385–395.
- Bister B, Bischoff D, Stroebele M, Riedlinger J, Reicke A, Wolter F, Bull AT, Zaehner H, Fiedler HP, Suessmuth RD. 2004. Abyssomicin C- A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew Chem Int Ed Engl. 43:2574–2576.
- Boumehira AZ, El-Enshasy HA, Hacène H, Elsayed EA, Aziz R, Park EY. 2016. Recent progress on the development of antibiotics from the genus Micromonospora. Biotechnol Bioproc E. 21(2):199–223.
- CLSI M07-A9. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved Standard-ninth edition. Wayne, PA: Clinical and Laboratory Standards Institute.
- Fiedler H-P, Bruntner C, Riedlinger J, Bull AT, Knutsen G, Goodfellow M, Jones A, Maldonado L, Pathom-Aree W, Beil W, et al. 2008. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J Antibiot. 61(3):158–163.
- Goodfellow M, Stach JE, Brown R, Bonda ANV, Jones AL, Mexson J, Fiedler H-P, Zucchi TD, Bull AT. 2012. Verrucosispora maris sp. nov., a novel deep-sea actinomycete isolated fromamarine sediment which produces abyssomicins. Antonie Van Leeuwenhoek 101(1):185–193.
- Huang P, Xie F, Ren B, Wang Q, Wang J, Wang Q, Abdel-Mageed W, Liu MM, Han JY, Oyeleye A, et al. 2016. Anti-MRSA and anti-TB metabolites from marine-derived Verrucosispora sp. MS100047. Appl Microbiol Biotechnol. 100(17):7437–7447.
- Kyeremeh K, Acquah KS, Camas M, Tabudravu J, Houssen W, Deng H, Jaspars M. 2014. Butrepyrazinone, a new pyrazinone with an unusual methylation pattern from a Ghanaian Verrucosispora sp.K51G. Mar Drugs 12(10):5197–5208.
- Li BY, Webster TJ. 2018. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res. 36:22–32.
- Manivasagan P, Venkatesan J, Sivakumar K, Kim SK. 2013. RETRACTED: marine actinobacterial metabolites: current status and future perspectives. Microbiol Res. 168(6):311–332.
- Medernach RL, Logan LK. 2018. The growing threat of antibiotic resistance in children. Infect Dis Clin North Am. 32(1):1–17.
- Nie YL, Wu YD, Wang CX, Lin R, Xie Y, Fang D-S, Jiang H, Lian YY. 2014. Compounds from marine-derived Verrucosispora sp.FIM06054 and their potential antitumour activities. Nat Prod Res. 28(23):2134–2139.
- Qiao M, Ying GG, Singer AC, Zhu YG. 2018. Review of antibiotic resistance in China and its environment. Environ Int. 110:160–172.
- Rheims H, Schumann P, Rohde M, Stackebrandt E. 1998. Verrucosispora gifhornensis gen. nov., sp. nov., a new member of the actinobacterial family Micromonosporaceae. Int J Syst Bacteriol. 48(4):1119–1127.
- Riedlinger J, Reicke A, Zähner H, Krismer B, Bull A, Maldonado L, Ward A, Goodfellow M, Bister B, Bischoff D, et al. 2004. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J Antibiot. 57(4):271–279.
- Shirai M, Okuda M, Motohashi K, Imoto M, Furihata K, Matsuo Y, Katsuta A, Shizuri Y, Seto H. 2010. Terpenoids produced by actinomycetes: isolation, structural elucidation and biosynthesis of new diterpenes, gifhornenolones A and B from Verrucosispora gifhornensis YM28-088. J Antibiot. 63(5):245–250.
- Wu QH, Chen JW, Li X, Chen S, Wang H. 2017. Advances in antimicrobial natural products derived from marine actinomycetes. Mini Rev Org Chem. 14:501–515.
- Wyche TP, Hou Y, Braun D, Cohen HC, Xiong MP, Bugni TS. 2011. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. J Org Chem. 76(16):6542–6547.